Correlation Between Kilitch Drugs and Sakar Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Sakar Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Sakar Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kilitch Drugs Limited and Sakar Healthcare Limited, you can compare the effects of market volatilities on Kilitch Drugs and Sakar Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Sakar Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Sakar Healthcare.

Diversification Opportunities for Kilitch Drugs and Sakar Healthcare

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Kilitch and Sakar is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Sakar Healthcare Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sakar Healthcare and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Sakar Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sakar Healthcare has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Sakar Healthcare go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Sakar Healthcare

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to generate 0.93 times more return on investment than Sakar Healthcare. However, Kilitch Drugs Limited is 1.08 times less risky than Sakar Healthcare. It trades about 0.03 of its potential returns per unit of risk. Sakar Healthcare Limited is currently generating about -0.03 per unit of risk. If you would invest  31,560  in Kilitch Drugs Limited on October 30, 2024 and sell it today you would earn a total of  455.00  from holding Kilitch Drugs Limited or generate 1.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kilitch Drugs Limited  vs.  Sakar Healthcare Limited

 Performance 
       Timeline  
Kilitch Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.
Sakar Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sakar Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward-looking signals, Sakar Healthcare is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Kilitch Drugs and Sakar Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kilitch Drugs and Sakar Healthcare

The main advantage of trading using opposite Kilitch Drugs and Sakar Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Sakar Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sakar Healthcare will offset losses from the drop in Sakar Healthcare's long position.
The idea behind Kilitch Drugs Limited and Sakar Healthcare Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets